Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A 3 Months Duration Interventional Study Comparing Hemodynamic Parameters Between Bolus and Fractionated Group. [Phase 1]
Phase 1 interventional trial comparing hemodynamic parameters between bolus and fractionated administration in benign prostatic hyperplasia;…
-
EMA safety_alert · 2024-10-04Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2024
PRAC has initiated a safety review of medicines containing finasteride and dutasteride to assess potential safety concerns. The review cover…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes [NA]
A completed randomized controlled trial comparing early apical release versus classic Holmium laser enucleation of the prostate evaluated po…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia
Completed clinical trial update for SOLTIVE laser enucleation used to treat benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)
Clinical trial update on duration of medication therapy and outcomes after holmium laser prostate surgery for benign prostatic hyperplasia; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-09-27FDA Approved: DOXAZOSIN — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for doxazosin, a generic product, likely updating labeling or manufacturing detail…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Optimized Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia [NA]
Clinical trial update for optimized water vapor thermal therapy for benign prostatic hyperplasia, sponsored by The Affiliated Nanjing Drum T…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Modified Water Vapor Thermal Therapy in Management of Patients With Large-volume Benign Prostatic Hyperplasia [NA]
Clinical trial update for Modified Water Vapor Thermal Therapy to manage large-volume benign prostatic hyperplasia; the study is not yet rec…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia [Phase 3]
A Phase 3 clinical trial evaluating tadalafil in patients with benign prostatic hyperplasia has completed. The study assessed tadalafil for …
-
FDA approval · 2024-08-22FDA Approved: TADALAFIL — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for tadalafil, updating the approved product.
-
FDA label_change · 2024-08-22FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approves a supplemental application for finasteride from Accord Healthcare, Inc., resulting in labeling changes.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia [Phase 3]
Extension Phase 3 study of vibegron for overactive bladder in men on BPH therapy has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms
European registry study evaluating transperineal laser ablation for lower urinary tract symptoms due to benign prostatic hyperplasia; curren…
-
FDA approval · 2024-08-16FDA Approved: SILODOSIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for silodosin.
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH) [NA]
An ongoing clinical trial compares Thulium Fiber Laser to Holmium MOSES for treating benign prostatic hyperplasia and is currently recruitin…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Tibial Nerve Stimulation for Post-BPH Overactive Bladder [Phase 3]
Phase 3 clinical trial evaluating tibial nerve stimulation for persistent overactive bladder symptoms after benign prostatic hyperplasia sur…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) [Phase 3]
This document reports the completion of a Phase 3 trial evaluating an investigational drug for benign prostatic hyperplasia (NCT00127179).
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP [NA]
This entry notes a clinical trial comparing high- versus low-power holmium laser enucleation of the prostate (HOLEP) for benign prostatic hy…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Evaluation of SureCore Plus Biopsy System [NA]
This update describes a clinical trial evaluating the SureCore Plus Biopsy System for benign prostatic hyperplasia. The study is not yet rec…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Slim Sheath 22F Holmium Laser Enucleation of the Prostate (HoLEP) vs 26 F Sheath HoLEP for BPH: RCT [NA]
A clinical trial sponsored by Thunder Bay Regional Health Research Institute evaluating Slim Sheath 22F HoLEP versus 26F sheath HoLEP for be…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) [Phase 3]
Phase 3 trial assessing efficacy, safety, and tolerability of vibegron in men with overactive bladder on BPH therapy has completed, with res…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients. [NA]
A completed pilot clinical trial assessing the safety and efficacy of the Butterfly Medical Prostatic Retraction Device in patients with ben…
-
FDA approval · 2024-07-29FDA Approved: TEZRULY — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved TEZRULY (terazosin) under ANI Pharmaceuticals' original NDA, bringing terazosin to market under a new brand for approved in…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia
This completed clinical trial evaluated the prevalence of bacteriuria in symptomatic benign prostatic hyperplasia, the antibiotic susceptibi…
-
FDA approval · 2024-07-18FDA Approved: DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Dutasteride and Tamsulosin Hydrochloride as an original generic combination product.